203 related articles for article (PubMed ID: 6327865)
1. Diagnostic evaluation of phosphoribosylpyrophosphate synthetase activities in hemolysates.
Losman MJ; Hecker S; Woo S; Becker MA
J Lab Clin Med; 1984 Jun; 103(6):932-43. PubMed ID: 6327865
[TBL] [Abstract][Full Text] [Related]
2. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
Becker MA; Losman MJ; Itkin P; Simkin PA
J Lab Clin Med; 1982 Apr; 99(4):495-511. PubMed ID: 6174658
[TBL] [Abstract][Full Text] [Related]
3. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.
Zoref E; De Vries A; Sperling O
J Clin Invest; 1975 Nov; 56(5):1093-9. PubMed ID: 171280
[TBL] [Abstract][Full Text] [Related]
4. Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.
Becker MA
J Clin Invest; 1976 Feb; 57(2):308-18. PubMed ID: 176178
[TBL] [Abstract][Full Text] [Related]
5. Human phosphoribosylpyrophosphate synthetase: radioimmunochemical quantitation in erythrocytes and fibroblasts.
Itkin P; Woo S; Becker MA
J Lab Clin Med; 1984 Jul; 104(1):96-109. PubMed ID: 6330252
[TBL] [Abstract][Full Text] [Related]
6. A gouty family with increased phosphoribosylpyrophosphate synthetase activity: case reports, familial studies, and kinetic studies of the abnormal enzyme.
Akaoka I; Fujimori S; Kamatani N; Takeuchi F; Yano E; Nishida Y; Hashimoto A; Horiuchi Y
J Rheumatol; 1981; 8(4):563-74. PubMed ID: 6271966
[TBL] [Abstract][Full Text] [Related]
7. Decreased erythrocyte phosphoribosylpyrophosphate synthetase activity and impaired formation in thalassemia minor: a mechanism for decreased adenine nucleotide content.
Zerez CR; Lachant NA; Tanaka KR
J Lab Clin Med; 1989 Jul; 114(1):43-50. PubMed ID: 2544652
[TBL] [Abstract][Full Text] [Related]
8. [Phosphoribosylpyrophosphate synthetase anomalies in 2 cases of gout beginning at an early age].
Lejeune E; Bouvier M; Mousson B; Llorca G; Baltassat P
Rev Rhum Mal Osteoartic; 1979; 46(7-9):457-65. PubMed ID: 228383
[TBL] [Abstract][Full Text] [Related]
9. [PRPP synthetase superactivity].
Fujimori S
Nihon Rinsho; 1996 Dec; 54(12):3309-14. PubMed ID: 8976111
[TBL] [Abstract][Full Text] [Related]
10. Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorineural deafness.
Becker MA; Puig JG; Mateos FA; Jimenez ML; Kim M; Simmonds HA
Am J Med; 1988 Sep; 85(3):383-90. PubMed ID: 2843048
[TBL] [Abstract][Full Text] [Related]
11. Variant human phosphoribosylpyrophosphate synthetase altered in regulatory and catalytic functions.
Becker MA; Raivio KO; Bakay B; Adams WB; Nyhan WL
J Clin Invest; 1980 Jan; 65(1):109-20. PubMed ID: 6243137
[TBL] [Abstract][Full Text] [Related]
12. Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme.
Becker MA; Losman MJ; Rosenberg AL; Mehlman I; Levinson DJ; Holmes EW
Arthritis Rheum; 1986 Jul; 29(7):880-8. PubMed ID: 3017368
[TBL] [Abstract][Full Text] [Related]
13. Normal activity of metabolic pathways involved in the formation and utilization of phosphoribosylpyrophosphate in erythrocytes of patients with primary metabolic gout.
Sperling O; Boer P; Brosh S; Elazar E; Szeinberg A; de Vries A
Nutr Metab; 1975; 18(4):217-23. PubMed ID: 172821
[TBL] [Abstract][Full Text] [Related]
14. Increased PRPP synthetase activity in cultured rat hepatoma cells containing mutations in the hypoxanthine-guanine phosphoribosyltransferase gene.
Graf LH; McRoberts JA; Harrison TM; Martin DW
J Cell Physiol; 1976 Jul; 88(3):331-42. PubMed ID: 178676
[TBL] [Abstract][Full Text] [Related]
15. [Increased activity of PRPP synthetase].
Iizasa T
Nihon Rinsho; 2008 Apr; 66(4):694-8. PubMed ID: 18409517
[TBL] [Abstract][Full Text] [Related]
16. Overproduction disease in man due to enzyme feedback resistance mutation. Purine overproduction in gout due to excessive activity of mutant feedback-resistant phosphoribosylpyrophosphate synthetase.
Sperling O; Boer P; Brosh S; Zoref E; de Vries A
Enzyme; 1978; 23(1):1-9. PubMed ID: 203449
[TBL] [Abstract][Full Text] [Related]
17. [Spectrophotometric assay of 5-phosphoribosyl-1-pyrophosphate synthetase (PRPP) in erythrocyte lysate (author's transl)].
Micheli V; Taddeo A
Quad Sclavo Diagn; 1981 Jun; 17(2):209-15. PubMed ID: 6267652
[No Abstract] [Full Text] [Related]
18. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
Lachant NA; Zerez CR; Tanaka KR
Biochim Biophys Acta; 1989 Jan; 994(1):81-8. PubMed ID: 2535789
[TBL] [Abstract][Full Text] [Related]
19. Phosphoribosylpyrophosphate synthetase in human erythrocytes: assay and kinetic studies using high-performance liquid chromatography.
Sakuma R; Nishina T; Yamanaka H; Kamatani N; Nishioka K; Maeda M; Tsuji A
Clin Chim Acta; 1991 Dec; 203(2-3):143-52. PubMed ID: 1663846
[TBL] [Abstract][Full Text] [Related]
20. Phosphoribosyl pyrophosphate synthetase and glutathione reductase in erythrocytes from hyperuricaemic and gout patients.
Hardwell TR; Braven J; Shaw S; Whittaker M
Clin Chim Acta; 1982 Dec; 126(3):217-26. PubMed ID: 6295664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
